Kelly Anderson/X
Aug 18, 2026, 19:35
Kelly Anderson: Factor XIa Inhibition for Secondary Stroke Prevention
Kelly Anderson, Healthcare Expert, shared Medscape‘s post on X:
“Factor XIa inhibition is an exciting approach to secondary stroke prevention because it aims to reduce thrombosis while potentially limiting bleeding risk.”
Medscape shared a post on X:
“What’s the evidence behind factor XIa inhibition in secondary stroke prevention?
Explore the pharmacologic rationale, emerging clinical data, and patient profiles that may benefit from this evolving strategy.”
Stay updated with Hemostasis Today․
-
Aug 18, 2026, 19:49Make the Most of Your Summer and Catch Up on Gene Therapy – EAHAD
-
Aug 18, 2026, 19:46Lesley Van Wyk: ANA Testing – From Screening to Interpretation
-
Aug 18, 2026, 19:45Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
-
Aug 18, 2026, 19:42Melanie Jay: What Should Behavioral Support Look Like Alongside Obesity Medications?
-
Aug 18, 2026, 19:40Subodh Verma: Tirzepatide Improves Multiple Cardiovascular Risk Pathways
-
Aug 18, 2026, 19:37Boby Varkey Maramattom: Thrombolysis in Acute Ischemic Stroke With an Unruptured Aneurysm
-
Aug 18, 2026, 19:33Nebil Youssef: Deaths in Custody Raise New Questions for Syria’s Government
-
Aug 18, 2026, 19:32Ihab Suliman: A Snake Venom Helping Diagnose an Autoimmune Clotting Disorder?
-
Aug 18, 2026, 16:57New Insights Into Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon